Why is Neuland Labs. falling/rising?

As of 28-Aug, Neuland Laboratories Ltd is experiencing a price increase, currently at 13,264.85, reflecting a rise of 133.0 or 1.01%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite a recent outperformance against its sector by 1.85%, the stock has seen a significant drop in delivery volume, which fell by 49.52% against the 5-day average. Over the past week, the stock has underperformed with a return of -3.82%, while it has also declined by 4.04% over the past month. However, it has generated a positive return of 6.74% over the last year, outperforming the BSE500 in each of the last three annual periods. The company has a strong ability to service debt, indicated by a low Debt to EBITDA ratio of 0.57 times, and high institutional holdings at 33.66%, suggesting confidence from more informed investors.
In the broader market context, the stock's short-term performance has been weaker compared to the benchmark, with the Sensex declining by 2.34% over the past week and 1.00% over the past month. While Neuland Laboratories has shown consistent returns over the last three years, the company faces challenges with poor long-term growth, as evidenced by a decline in net sales and negative results over the last four consecutive quarters. The stock's valuation appears expensive with a Price to Book Value of 11.2, particularly in light of a significant profit drop of 58.9% over the past year. This combination of factors contributes to a complex outlook for the stock, balancing recent positive movements against underlying financial challenges.